Quantcast
Home > Quotes > EKSO

Ekso Bionics Holdings, Inc. Common Stock (EKSO) Quote & Summary Data

EKSO 
$1.995
*  
0.095
4.55%
Get EKSO Alerts
*Delayed - data as of Nov. 16, 2018  -  Find a broker to begin trading EKSO now
Exchange:NASDAQ
Industry: Capital Goods
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
3
Today's High / Low
$ 2.10 / $ 1.99
Share Volume
134,952
50 Day Avg. Daily Volume
305,381
Previous Close
$ 2.09
52 Week High / Low
$ 4.77 / $ 1.24
Market Cap
124,971,301
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.02

Intraday Chart

Shares Traded

Share Volume:
134,952
50 Day Avg. Daily Volume:
305,381

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.52

Trading Range

The current last sale of $1.995 is 60.89% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 2.10 $ 4.77
 Low: $ 1.99 $ 1.24

Company Description (as filed with the SEC)

We design, develop and sell exoskeleton technology that currently has applications in healthcare and industrial markets. Our wearable exoskeletons are worn over clothing and are mechanically controlled by a trained operator to augment human strength, endurance and mobility. Our exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. We have sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. We believe the commercial opportunity for exoskeleton technology adoption is accelerating as a result of recent advancements in material technologies, electronic and electrical engineering, control technologies, and sensor and software development.  ... More ...  


Risk Grade

Where does EKSO fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 2.10
Open Date:
Nov. 16, 2018
Close Price:
$ 2.09
Close Date:
Nov. 16, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x